BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
CXCL2
,
nitric oxide metabolic process
,
Allergy to pollen
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SLC7A11
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Establishment of SLC7A11-knockout mouse and its preliminary investigation in melanoma.
SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis.
Iron overload facilitates neonatal hypoxic-ischemic brain damage via SLC7A11-mediated ferroptosis.
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system funct…
Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting Slc7a11-media…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Association Between Ferroptosis and Epilepsy
Association Between PM2.5 and Ferroptosis
Association Between PM2.5 Exposure and Ferroptosis in Seizures Patients
Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ